Novo Nordisk in the NEWS
Novo Nordisk (NVO) and Cardior Pharmaceuticals announced that Novo Nordisk agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial . . .
This content is for paid subscribers.
Today’s Highlights
March 25, 2024
